XML 32 R23.htm IDEA: XBRL DOCUMENT
v3.23.2

STOCKHOLDERS EQUITY (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2023
STOCKHOLDERS EQUITY |
Schedule of reverse stock split on the basic and diluted net loss per share |
|  | Three |  |  | Three |  |  | Six |  |  | Six |
|  | Months Ended |  |  | Months Ended |  |  | Months Ended |  |  | Months Ended |
Historical per share data – (Pre- Split basis) |  | June 30, 2023 |  |  | June 30, 2022 |  |  | June 30, 2023 |  |  | June 30, 2022 |
Net loss attributable to common shareholders |  | $ | (980,273 | ) |  | $ | (1,188,760 | ) |  | $ | (4,799,685 | ) |  | $ | (5,371,098 | )
Net loss per common share - basic and diluted |  | $ | (0.06 | ) |  | $ | (0.08 | ) |  | $ | (0.28 | ) |  | $ | (0.36 | )
|  | Three |  |  | Three |  |  | Six |  |  | Six |
|  | Months Ended |  |  | Months Ended |  |  | Months Ended |  |  | Months Ended |
Historical per share data – (Post- Split basis) (UNAUDITED) |  | June 30, 2023 |  |  | June 30, 2022 |  |  | June 30, 2023 |  |  | June 30, 2022 |
Net loss attributable to common shareholders |  | $ | (980,273 | ) |  | $ | (1,188,760 | ) |  | $ | (4,799,685 | ) |  | $ | (5,371,098 | )
Net loss per common share - basic and diluted |  | $ | (0.94 | ) |  | $ | (1.20 | ) |  | $ | (4.20 | ) |  | $ | (5.45 | )
Schedule of reverse stock split on the condensed consolidated balance sheet |
|  |  |  |  |  |  |  | Pro-Forma Effect |
|  | June 30, |  |  |  |  |  | June 30, |
|  | 2023 |  |  | 1:15 Adjustment |  |  | 2023 |
ASSETS |  |  |  |  |  |  |  |  |
Total assets |  | $ | 11,202,109 |  |  | $ | - |  |  | $ | 11,202,109 |
Total liabilities |  |  | 9,342,147 |  |  |  | - |  |  |  | 9,342,147 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit): |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock, Series D, $0.0001 par value; 2,000,000 shares authorized; 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively |  |  | - |  |  |  |  |  |  |  | - |
Preferred stock, Series E, $0.0001 par value; 775,000 shares authorized; 86,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively |  |  | 9 |  |  |  |  |  |  |  | 9 |
Preferred stock, Series F, $0.0001 par value; 200,000 shares authorized; 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively |  |  | - |  |  |  |  |  |  |  | - |
Common stock, $0.0001 par value; 100,000,000 shares authorized; 17,792,151 and 16,277,764 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively |  |  | 1,780 |  |  |  | (1,662 | ) |  |  | 118 |
Shares to be issued, 587,945 shares as of March 31, 2023 and December 31, 2022 |  |  | - |  |  |  | - |  |  |  | - |
Additional paid-in capital |  |  | 75,913,399 |  |  |  | 1,662 |  |  |  | 75,915,061 |
Accumulated deficit |  |  | (74,055,226 | ) |  |  |  |  |  |  | (74,055,226 | )
Total stockholders' equity |  |  | 1,859,962 |  |  |  | - |  |  |  | 1,859,962 |
|  |  |  |  |  |  |  |  |  |  | - |
Total liabilities and stockholders' equity |  | $ | 11,202,109 |  |  |  | - |  |  | $ | 11,202,109 |
|  |  |  |  |  |  |  | Pro-Forma Effect |
|  | December 31, |  |  |  |  |  | December 31, |
|  | 2022 |  |  | 1:15 Adjustment |  |  | 2022 |
ASSETS |  |  |  |  |  |  |  |  |
Total assets |  | $ | 14,133,284 |  |  | $ | - |  |  | $ | 14,133,284 |
Total liabilities |  |  | 9,054,967 |  |  |  | - |  |  |  | 9,054,967 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit): |  |  |  |  |  |  |  |  |  |  |  |
Preferred stock, Series D, $0.0001 par value; 2,000,000 shares authorized; 0 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively |  |  | - |  |  |  |  |  |  |  | - |
Preferred stock, Series E, $0.0001 par value; 775,000 shares authorized; 86,000 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively |  |  | 9 |  |  |  |  |  |  |  | 9 |
Preferred stock, Series F, $0.0001 par value; 200,000 shares authorized; 0 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively |  |  | - |  |  |  |  |  |  |  | - |
Common stock, $0.0001 par value; 100,000,000 shares authorized; 16,277,764 and 14,566,420 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively |  |  | 1,629 |  |  |  | (1,520 | ) |  |  | 109 |
Shares to be issued, 587,945 shares as of December 31, 2022 and December 31, 2021 |  |  | 59 |  |  |  | (55 | ) |  |  | 4 |
Additional paid-in capital |  |  | 74,332,161 |  |  |  | 1,575 |  |  |  | 74,333,736 |
Accumulated deficit |  |  | (69,255,541 | ) |  |  |  |  |  |  | (69,255,541 | )
Total stockholders' equity |  |  | 5,078,317 |  |  |  | - |  |  |  | 5,078,317 |
|  |  |  |  |  |  |  |  |  |  | - |
Total liabilities and stockholders' equity |  | $ | 14,133,284 |  |  |  | - |  |  | $ | 14,133,284 |
Schedule Of Restricted Stock Grant Activity |
|  | Stock Awards |
Outstanding at December 31, 2021 |  |  | 146,000 |
Granted |  |  | 95,825 |
Vested |  |  | (88,325 | )
Vested and issuable |  |  | (7,500 | )
Forfeited or cancelled |  |  | - |
Outstanding at December 31, 2022 |  |  | 146,000 |
Granted |  |  | - |
Vested and issued |  |  | (110,800 | )
Vested and issuable |  |  | (35,200 | )
Outstanding at June 30, 2023 |  |  | - |

X
- References No definition available. + Details
Name: | rcrt_ScheduleOfReverseStockSplitOnTheBasicAndDilutedNetLossPerShareTableTextBlock
Namespace Prefix: | rcrt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | rcrt_ScheduleOfReverseStockSplitOnTheCondensedConsolidatedBalanceSheetTableTxtBlock
Namespace Prefix: | rcrt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | rcrt_ScheduleOfrestrictedStockGrantActivitytabletextblock
Namespace Prefix: | rcrt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration